There was also news this month in February about Eron Musk’s Neuralink, Inc. Unfortunately, Neuralink is currently under investigation for improper packaging in the transportation of chip materials and transporting materials with infectious pathogens. There is an investigation into the company’s failure to provide qualified training to its employees. It is unfortunate to report that this incident will further delay Neuralink’s highly anticipated human clinical trials.
Feb 2023, reported by Nobuko Schlough